Login Register Cart 0
Generic placeholder image

Mini-Reviews in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1389-5575
ISSN (Online): 1875-5607

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Biography

Meet the Editorial Board Member

Author(s): Frank Wuest

Volume 24, Issue 5, 2024

Published on: 09 November, 2023

Page: [479 - 479] Pages: 1

DOI: 10.2174/138955752405231109211935

Price: $65

Next »
[1]
O. Tietz, A. Marshall, C. Bergman, M. Wuest, F. Wuest. Impact of Structural Alterations on the Radiopharmacological Profile of 18F-labeled Pyrimidines as Cyclooxygenase-2 (COX-2) Imaging Agents. Nucl. Med. Biol., 2018, 62-63, 9-17.
[2]
I. Hamann, D. Krys, V. Bouvet, D. Glubrecht, A. Marshall, C. Bergman, L. Vos, J. R. Mackey, M. Wuest, F. Wuest. Imaging hypoxia-driven regulation of metabolic markers in breast cancer: Role of GLUT1, GLUT2 and GLUT5. FASEB J,
[3]
B. J. Al-Hourani, B. F. Ali, Z. Judeh, M. I. El-Barghouthi, W. Al-Awaida, Y. Snobar, F. El Soubani, K. Matalqah, F. Wuest. Unexpected formation of 1-[4-chloromethylphenyl]-5-[4-(methyl-sulfonyl)benzyl]-1H-tetrazole and 1-[4-chloromethylphenyl]-5-[4-(aminosulfonyl)-phenyl]-1H-tetrazole: Crystal structure, bioassay screening and molecular docking studies. J. Mol. Struct., 2018, 1164, 317-327.
[4]
M. Wagner, M. Wuest, I. Hamann, A. Lopez-Campistrous, T. McMullen, F. Wuest. Molecular imaging of platelet-derived growth factor receptor-alpha (PDGFRa) in papillary thyroid cancer using immuno-PET. Nucl. Med. Biol., 2018, 58, 51-58.
[5]
M. Wuest, I. Hamann, V. Bouvet, D. Glubrecht, A. Marshall, B. Trayner, O.-M. Soueidan, D. Krys, M. Wagner, C. Cheeseman, F. West, F. Wuest. Molecular Imaging of GLUT1 and GLUT5 in Breast Cancer: A Multitracer PET Imaging Study in Mice. Mol. Pharmacol., 2018, 93, 79-89.
[6]
S. Berke, A.-L. Kampmann, M. Wuest, J. J. Bailey, B. Glowacki F. Wuest, K. Jurkschat, R. Weberskirch, R. Schirrmacher. 18F-Radiolabeling and In Vivo Analysis of SiFA-derivatized Polymeric Core-Shell Nanoparticles. Bioconjug. Chem., 2018, 29, 89-95.
[7]
T. Kniess, M. Laube, F. Wuest, J. Pietzsch. Technetium-99m based Small Molecule Radiopharmaceuticals and Radiotracers Targeting Inflammation and Infection. Dalton Trans., 2017, 46, 14435-14451.
[8]
V. Bouvet, M. Wuest, J. Bailey, C. Bergman, N. Janzen, J. F. Valliant, F. Wuest. Targeting prostate-specific membrane antigen (PSMA) with 18F-labeled compounds: The influence of prosthetic groups on tumor uptake and clearance profile. Mol. Imaging Biol., 2017, 19, 923-932.
[9]
G. Meng, X. Tang, Z. Yang, M. M. Benesch, A. Marshall, D. Murray, D. G. Hemmings, F. Wuest, T. P. McMullen, D. N. Brindley. Implications for breast cancer treatment from increased autotaxin production in adipose tissue after radiotherapy. FASEB J., 2017, 31, 4064-4077.
[10]
O.-M. Soueidan, T. W. Scully, J. Kaur, R. Panigrahi, A. Belovodskiy, V. Do, C. Matier, J. Lemieux, F. Wuest, C. I. Cheeseman, F. G. West. Fluorescent hexose derivatives establish stringent stereochemical requirement by GLUT5 for recognition and transport of monosaccharides. ACS Chem. Biol., 2017, 12, 1087-1094.
[11]
A. Bhardwaj, J. Kaur, M. Wuest, F. Wuest. In Situ Click Chemistry Generation of Cyclooxygenase-2 Inhibitors. Nature Commun., 2017, 8, 1.

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy